CompletedNCT06190483
Diazepam and brain chemistry related to psychosis risk
About this title
Read the official source — NCT06190483Medication studyAges 18–40United KingdomSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 40 years.
- Listed locations
- LondonSee all locations and recruitment
Study information
Study start dateStarted: July 24, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- King's College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United Kingdom
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT06190483
- Official title
Show the full official title
Effect of Benzodiazepine on Corticolimbic Activation, GABA and Glutamate in Subjects at Clinical High Risk of Psychosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is King's College London, a university.
Did this study involve medication?
Yes. The study involved medication, including Diazepam 5 Mg Oral Tablet and Ascorbic Acid 50 Mg Oral Tablet.
Who was this study for?
Listed age limits: 18 years to 40 years.
